Clinical Trial Update: Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis

View source ↗

Summary

A completed clinical trial evaluating the impact of nirsevimab on emergency department use for bronchiolitis associated with Respiratory Syncytial Virus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Nirsevimab (nirsevimab)

Snippet

Sponsor: Hôpital Armand Trousseau | Conditions: Bronchiolitis, Respiratory Syncytial Virus (RSV) | Status: COMPLETED